Showing results (1701-1710 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|September 11, 2018
Field evaluation of GeneXpertMomoko Iwamoto, Aurelie Calzia, Amelie Dublineau, et al.Journal of Viral Hepatitis|September 11, 2018
Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patientsJuan Macías, Francisco Téllez, Antonio Rivero-Juárez, et al.Journal of Viral Hepatitis|August 17, 2018
Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen-negative chronic infection patients: A population-based prospective cohortLiguo Zhu, Xiangjun Zhai, Qungang Wang, et al.Journal of Viral Hepatitis|August 17, 2018
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosisChiara Masetti, Raffaella Lionetti, Marinella Lupo, et al.Journal of Viral Hepatitis|August 17, 2018
Association of Toll-like receptor 4 polymorphism with hepatitis E virus-infected Indian patientsRavi P Arya, Nischay Mishra, Kakali Biswas, et al.Journal of Viral Hepatitis|July 13, 2018
Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV eliminationMartin Kåberg, Georg Navér, Anders Hammarberg, et al.Journal of Viral Hepatitis|July 13, 2018
CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patientsMotonobu Nomura, Masataka Tsuge, Takuro Uchida, et al.Journal of Viral Hepatitis|July 13, 2018
Mortality, liver transplantation and hepatic complications in patients with treatment-naïve chronic hepatitis B treated with entecavir vs tenofovirByung Gyu Kim, Neung Hwa Park, Seung Bum Lee, et al.Journal of Viral Hepatitis|September 15, 2016
Occult hepatitis B virus infection: clinical implications in tuberculosis treatmentC Trigo, P E A A do Brasil, M J M Costa, et al.Journal of Viral Hepatitis|May 5, 2017
Efficacy of 12 or 18 weeks of elbasvir plus grazoprevir with ribavirin in treatment-naïve, noncirrhotic HCV genotype 3-infected patientsE Gane, R Nahass, V Luketic, et al.Pageof 362